Breaking News
Get 50% Off 0
Unlock Premium Data: Up to 50% Off InvestingPro CLAIM SALE
Close

Manulife Efficiency Selected Mixed Type Fund (162207)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.280 -0.010    -0.62%
21/06 - Closed. Currency in CNY ( Disclaimer )
  • Morningstar Rating:
  • Total Assets: 408.63M
Type:  Fund
Market:  China
Issuer:  MANULIFE TEDA Fund Mgmt Co.,Ltd
ISIN:  CNE000001MR3 
Asset Class:  Equity
MANULIFE TEDA Efficiency Selected Mixed Type Fund 1.280 -0.010 -0.62%

162207 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the MANULIFE TEDA Efficiency Selected Mixed Type Fund (162207) fund. Our MANULIFE TEDA Efficiency Selected Mixed Type Fund portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 9.520 9.520 0.000
Stocks 69.740 69.740 0.000
Bonds 19.410 19.410 0.000
Other 1.340 1.340 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 23.697 17.069
Price to Book 3.892 2.514
Price to Sales 4.354 1.999
Price to Cash Flow 20.946 9.879
Dividend Yield 1.141 2.442
5 Years Earnings Growth 18.989 16.801

Sector Allocation

Name  Net % Category Average
Healthcare 82.000 14.638
Technology 9.320 21.644
Industrials 3.940 18.902
Basic Materials 2.990 11.271
Consumer Cyclical 1.740 10.273

Region Allocation

  • Asia
  • Emerging Markets

Top Holdings

Number of long holdings: 57

Number of short holdings: 1

Name ISIN Weight % Last Change %
  WuXi AppTec CNE1000031K4 8.67 40.49 -1.46%
TREASURY COUPON BOND 2023 24 - 8.61 - -
  Shenzhen Mindray Bio-Medical CNE100003G67 8.35 293.34 -0.50%
  Jiangsu Hengrui CNE0000014W7 8.21 40.04 -1.38%
AGRICULTURAL DEVELOPMENT BANK OF CHINA BOND 2021 2 - 7.40 - -
  NAURA Technology CNE100000ML7 6.07 330.11 -0.13%
  Chongqing Zhifei Bio Products CNE100000V20 6.04 28.78 +0.70%
  Hunan Jiudian Pharma CNE1000034Z6 5.74 27.58 +5.71%
THE EXPORT-IMPORT BANK OF CHINA BOND 2020 11 - 5.13 - -
  Shanghai Aohua Photoelectricity Endoscope CNE100004ZJ5 4.63 47.48 -2.62%

Top Equity Funds by MANULIFE Fund Mgmt Co.,Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  Manulife TEDA Trsfmtn Opportunity E 3.88B 16.64 -6.97 -
  MANULIFE TEDA RuiZhi WJ Alloc 1.37B -2.53 5.04 -
  TEDA Value Optimization Growth Ind 983.01M 19.12 -4.40 7.15
  MANULIFE TEDA Market Value Selectio 946M 20.02 -5.32 6.75
  TEDA Value Optimization Cycle Ind 710.35M 16.08 4.71 14.07
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

162207 Comments

Write your thoughts about Manulife Efficiency Selected Mixed Type Fund
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email